Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,840.00
-40.00 (-0.68%)
At close: Apr 20, 2026

Sinsin Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
88,59688,89982,37694,66484,65197,850
Market Cap Growth
12.74%7.92%-12.98%11.83%-13.49%-29.43%
Enterprise Value
128,105131,411122,361135,899130,024145,574
Last Close Price
5840.005860.005354.846085.515387.796171.41
PE Ratio
9.539.5716.8520.2319.18-
PS Ratio
0.780.780.770.920.921.32
PB Ratio
1.191.191.261.531.421.79
P/TBV Ratio
1.191.201.261.531.431.80
P/FCF Ratio
12.7112.7518.56-18.59-
P/OCF Ratio
10.3210.3613.8624.0915.504220.66
EV/Sales Ratio
1.131.161.151.331.411.97
EV/EBITDA Ratio
8.578.8010.9713.6714.1662.51
EV/EBIT Ratio
11.8712.1817.7622.6423.96-
EV/FCF Ratio
18.3818.8527.57-28.56-
Debt / Equity Ratio
0.590.590.700.720.730.84
Debt / EBITDA Ratio
2.922.924.094.484.7319.85
Debt / FCF Ratio
6.276.2710.27-9.55-
Net Debt / Equity Ratio
0.530.530.690.710.690.83
Net Debt / EBITDA Ratio
2.672.674.044.444.4919.51
Net Debt / FCF Ratio
5.715.7110.15-40.849.06-17.09
Asset Turnover
0.850.850.840.840.780.64
Inventory Turnover
3.873.874.344.604.984.60
Quick Ratio
0.640.640.560.590.710.76
Current Ratio
0.980.980.870.911.061.08
Return on Equity (ROE)
13.25%13.25%7.54%7.64%7.62%-2.61%
Return on Assets (ROA)
5.05%5.05%3.39%3.06%2.88%-0.72%
Return on Invested Capital (ROIC)
8.95%9.08%5.95%5.80%5.40%-1.35%
Return on Capital Employed (ROCE)
14.00%14.00%9.80%8.30%6.90%-1.70%
Earnings Yield
10.49%10.45%5.93%4.94%5.21%-1.51%
FCF Yield
7.87%7.84%5.39%-1.14%5.38%-2.72%
Payout Ratio
9.80%9.80%18.62%16.21%--
Buyback Yield / Dilution
0.15%0.15%-0.07%---
Total Shareholder Return
1.17%0.15%-0.07%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.